William Paul Glezen

William Paul Glezen's AcademicInfluence.com Rankings

William Paul Glezen

Philosophy

#7212

World Rank

#10393

Historical Rank

Logic

#4277

World Rank

#5548

Historical Rank

philosophy Degrees

William Paul Glezen

Biology

#9795

World Rank

#13042

Historical Rank

Virology

#228

World Rank

#235

Historical Rank

Microbiology

#540

World Rank

#603

Historical Rank

Immunology

#592

World Rank

#612

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

William Paul Glezen's Degrees

PhD Microbiology Stanford University
Doctorate Medicine Stanford University

Why Is William Paul Glezen Influential?

(Suggest an Edit or Addition)

(See a Problem?)

William Paul Glezen's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Risk of primary infection and reinfection with respiratory syncytial virus. (1986) (1375)
The Japanese experience with vaccinating schoolchildren against influenza. (2001) (854)
Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. (1981) (635)
Impact of respiratory virus infections on persons with chronic underlying conditions. (2000) (562)
Interpandemic influenza in the Houston area, 1974-76. (1978) (408)
Effectiveness of live, attenuated intranasal influenza virus vaccine in healthy, working adults: a randomized controlled trial. (1999) (403)
Emerging infections: pandemic influenza. (1996) (307)
Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. (2005) (283)
Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. (1996) (280)
Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. (1993) (269)
Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. (1971) (264)
Patterns of shedding of myxoviruses and paramyxoviruses in children. (1981) (252)
Mycoplasma pneumoniae disease: clinical spectrum, pathophysiology, epidemiology, and control. (1971) (248)
Protection of infants from infection with influenza A virus by transplacentally acquired antibody. (1980) (244)
Influenza virus infections in infants. (1997) (244)
Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981. (1987) (220)
Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women. (2003) (218)
Parainfluenza virus type 3: seasonality and risk of infection and reinfection in young children. (1984) (208)
Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. (2003) (196)
Serious morbidity and mortality associated with influenza epidemics. (1982) (185)
Safety of influenza vaccination during pregnancy. (2005) (168)
Spectrum of Clinical Illness in Hospitalized Patients with “Common Cold” Virus Infections (2000) (166)
Respiratory viral infections in patients with chronic, obstructive pulmonary disease (2004) (165)
Influenza: its control in persons and populations. (1986) (161)
Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. (1985) (152)
Dual Respiratory Virus Infections (1997) (149)
Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. (1991) (141)
Influenza in children. Relationship to other respiratory agents. (1980) (138)
Group A streptococci, mycoplasmas, and viruses associated with acute pharyngitis. (1967) (135)
Acute respiratory disease associated with influenza epidemics in Houston, 1981-1983. (1987) (130)
Respiratory disease in group day care. (1972) (128)
Maternal immunization against viral disease. (1998) (125)
Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. (1975) (120)
Trivalent Live Attenuated Intranasal Influenza Vaccine Administered During the 2003–2004 Influenza Type A (H3N2) Outbreak Provided Immediate, Direct, and Indirect Protection in Children (2007) (117)
Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial (2005) (116)
Breast-feeding and respiratory virus infection. (1982) (114)
Live attenuated and inactivated influenza vaccine in school-age children. (1990) (113)
Effect of maternal antibodies on the infant immune response. (2003) (113)
Mortality and influenza. (1982) (110)
Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. (2001) (108)
Transplacental antibody transfer following maternal immunization with polysaccharide and conjugate Haemophilus influenzae type b vaccines. (1995) (105)
Clinical practice. Prevention and treatment of seasonal influenza. (2008) (100)
Herd protection against influenza. (2006) (98)
Studies on the role of viruses, bacteria, and M. pneumoniae as causes of lower respiratory tract infections in children. (1968) (98)
Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. (1991) (94)
Antigenicity and reactogenicity of influenza A/USSR/77 virus vaccine in children--a multicentered evaluation of dosage and safety. (1983) (93)
Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. (2010) (93)
Direct and total effectiveness of the intranasal, live-attenuated, trivalent cold-adapted influenza virus vaccine against the 2000-2001 influenza A(H1N1) and B epidemic in healthy children. (2004) (92)
Maternal immunization with Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine in The Gambia. (1996) (90)
Considerations of the risk of influenza in children and indications for prophylaxis. (1980) (90)
Epidemiologic observations of influenza B virus infections in Houston, Texas, 1976-1977. (1980) (88)
Infection with influenza A/Victoria virus in Houston families, 1976 (1981) (85)
Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. (2003) (84)
Acute respiratory disease of university students with special reference to the etiologic role of Herpesvirus hominis. (1975) (83)
Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus. (2007) (75)
Influenza B virus infections in the community and the family. The epidemics of 1976-1977 and 1979-1980 in Houston, Texas. (1983) (72)
HLA-restricted CD8+ cytotoxic T lymphocyte, interferon-gamma, and interleukin-4 responses to respiratory syncytial virus infection in infants and children. (2001) (70)
Improving influenza immunization in pregnant women and healthcare workers. (2010) (67)
Studies on reactogenicity and immunogenicity of attenuated bivalent cold recombinant influenza type A (CRA) and inactivated trivalent influenza virus (TI) vaccines in infants and young children. (1993) (65)
Effectiveness of rimantadine prophylaxis of children within families. (1986) (61)
Reinfection with influenza A (H3N2) virus in young children and their families. (1979) (60)
The influenza herald wave. (1982) (57)
Estimating deaths due to influenza and respiratory syncytial virus. (2003) (54)
Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004. (2007) (54)
Potentiation of the immune response to influenza virus subunit vaccines. (1977) (53)
Morbidity associated with the major respiratory viruses. (1990) (53)
Safety of the Intranasal, Trivalent, Live Attenuated Influenza Vaccine (LAIV) in Children With Intermittent Wheezing in an Open-Label Field Trial (2008) (52)
The Changing Epidemiology of Respiratory Syncytial Virus and Influenza: Impetus for New Control Measures (2004) (49)
Acquisition of serum antibodies to specific viral glycoproteins of parainfluenza virus 3 in children (1984) (49)
Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children. (1987) (48)
Combination vaccines for childhood immunization. (1999) (47)
Reactogenicity and immunogenicity of bivalent influenza A and monovalent influenza B virus vaccines in high-risk children. (1977) (44)
Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection. (1995) (44)
Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants (2001) (40)
Viral pneumonia as a cause and result of hospitalization. (1983) (39)
Haemophilus influenzae type b-specific antibody in infants after maternal immunization. (1997) (39)
Commentary: benefits of influenza vaccine in US elderly--new studies raise questions. (2006) (37)
Clinical and radiographic assessment of acute lower respiratory tract disease in infants and children. (1987) (36)
Asthma, influenza, and vaccination. (2006) (36)
Maternal immunization with the capsular polysaccharide vaccine for Haemophilus influenzae type b. (1992) (35)
Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. (2000) (33)
Cold-adapted, live attenuated influenza vaccine (2004) (32)
Fatal influenza B virus pneumonia in pediatric patients. (1992) (32)
Maternal immunization with Haemophilus influenzae type b vaccines in different populations. (2003) (32)
Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States (1996) (31)
USE OF MICRO TECHNIQUE FOR SERUM NEUTRALIZATION AND VIRUS IDENTIFICATION. (1965) (30)
Controlled Study of aNew Five-Component Acellular Pertussis Vaccine in Adults and Young Children (1992) (30)
Universal Influenza Vaccination and Live Attenuated Influenza Vaccination of Children (2008) (29)
Diurnal variation in responses to influenza vaccine. (1995) (29)
Quantitative relationship of preexisting homotypic antibodies to the excretion of attenuated poliovirus type 1. (1966) (29)
Aspirin and Reye's syndrome. (1982) (28)
Quantitative relationship of preexisting homotypic antibodies to excretion of poliovirus types 1, 2, and 3 following the feeding of trivalent attenuated poliovirus vaccine. (1969) (27)
Safety of influenza vaccination during pregnancy. Authors' reply (2006) (27)
Herpesvirus hominis encephalitis. Virus isolation from brain biopsy in seven patients and results of therapy. (1973) (26)
Control of influenza. (2004) (26)
Herd Protection Against Influenza (2006) (25)
Significance of mycoplasma infections in children with respiratory disease. (1967) (25)
Trivalent, inactivated influenza virus vaccine in children with sickle cell disease. (1983) (24)
Molecular epidemiology of influenza A(H3N2) virus reinfections. (2002) (23)
The Parainfluenza Viruses (1976) (22)
First International Symposium on Influenza and Other Respiratory Viruses: summary and overview (1999) (21)
Viral Diseases of the Fetus and Newborn (1979) (21)
Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons (1983) (21)
Influenza vaccination for healthy children (2002) (20)
Patterns of virus infections in families with acute respiratory illnesses. (1967) (18)
Cell-culture-derived influenza vaccine production (2011) (18)
Pulmonary nocardiosis in childhood. A case report. (1967) (18)
Picornavirus, the Most Common Respiratory Virus Causing Infection among Patients of All Ages Hospitalized with Acute Respiratory Illness (2011) (18)
Editorial commentary: Changing epidemiology of influenza B virus. (2014) (18)
Passive immunization for the prevention of otitis media. (2000) (16)
Mycoplasma pneumoniae infection in a resident boys' home. (1967) (16)
Epidemic pyoderma caused by nephritogenic streptococci in college athletes. (1972) (16)
Controlled study of a new five-component acellular pertussis vaccine in adults and young children. (1992) (16)
A field evaluation of inactivated, zonal-centrifuged influenza vaccines in children in Chapel Hill, North Carolina, 1968-69. (1969) (16)
A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults. (1981) (16)
Why no effect of maternal respiratory syncytial virus-neutralizing antibody? (2003) (15)
How did the 2008-2009 seasonal influenza vaccine affect the pandemic? (2010) (15)
Serological evidence of Hantaan virus infection in the United States. (1985) (15)
Pathogenesis of bronchiolitis--epidemiologic considerations. (1977) (15)
Modifying Clinical Practices to Manage Influenza in Children Effectively (2008) (14)
Humoral and cellular immune responses to an inactivated Mycoplasma pneumoniae vaccine in children. (1973) (14)
Immunogenic protein contaminants in pneumococcal vaccines. (2003) (14)
Salmonella in two poultry processing plants. (1966) (14)
Parainfluenza virus infections. (1974) (14)
Maternal vaccines. (2001) (14)
Echo 4 illness. Epidemiological, clinical and laboratory studies of an outbreak in a rural community. (1966) (14)
Safety and effectiveness of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children (2001) (13)
An influenza B epidemic among children in day-care. (1976) (13)
Maternal immunization. (1999) (13)
Influenza C virus infection. (1980) (12)
Influenza control--unfinished business. (1999) (12)
Etiologic studies of acute respiratory illness among children attending public schools. (1967) (12)
A personnel time-motion study of intranasal influenza vaccination in healthy children. (2005) (12)
HETEROGENEITY OF INFLUENZA VIRUSES ISOLATED FROM THE HOUSTON COMMUNITY DURING DEFINED EPIDEMIC PERIODS (1981) (12)
The new nasal spray influenza vaccine. (2001) (12)
Effect of passive antibody on parainfluenza virus type 3 pneumonia in hamsters (1976) (12)
Influenza surveillance in an urban area. (1993) (10)
Antipyretic use among children during the 1983 influenza season. (1985) (9)
Viral and Mycoplasmal Infections of the Respiratory Tract. (1974) (9)
Surveillance of influenza in Houston, Texas, USA: gradual transition from A/Victoria/75 (H3N2) to A/Texas/77 (H3N2) predominance and antigenic characterization of "intermediate" strains. (1983) (9)
Benefits of a universal influenza immunization program: more than the reduction in the use of antibiotics. (2009) (9)
Nosocomial influenza in a general hospital for indigent patients. (1991) (8)
Live attenuated intranasal influenza vaccine. (2002) (8)
Reactive airway disorders in children. Role of respiratory virus infections. (1984) (8)
Antecedents of chronic and recurrent lung disease. Childhood respiratory trouble. (1989) (8)
Alternative approaches to immunization of children with inactivated influenza virus vaccines. (1977) (8)
Evidence of interferon production in the hamster lung after primary or secondary exposure to parainfluenza virus type 3. (1982) (8)
Broadening indications for maternal influenza vaccination. (2011) (7)
Indications for amantadine in otherwise healthy children. (1993) (6)
Epidemiology and molecular characterization of co-circulating influenza A/H3N2 virus variants in children: Houston, Texas, 1997–8 (2003) (6)
Association of placental transfer of anti-Haemophilus influenzae type b polysaccharide antibodies with their V regions. (1996) (6)
Prevention of neonatal tetanus. (1998) (6)
770 PATHOGENESIS OF RESPIRATORY SYNCYTIAL (RS) VIRUS BRONCHIOLITIS IN INFANTS (1978) (6)
Booster effect of oral poliovaccine. Trials in persons previously immunized with inactivated vaccine. (1969) (6)
Respiratory syncytial virus: back to basics. (2009) (5)
Epidemiological perspective of breastfeeding and acute respiratory illnesses in infants. (1991) (5)
The pediatrician's role in influenza control (1986) (5)
Combating the Threat of Pandemic Influenza: Drug Discovery Approaches (2008) (5)
Infection and chronic granulomatous disease. (1974) (5)
Influenza and hospitalizations in children. (2000) (4)
Contribution of respiratory viruses to the worldwide problem of pneumonia in young children (1995) (4)
Safety of cold-adapted live influenza vaccine. (2004) (4)
Influenza prophylaxis for children. (1977) (4)
Viral respiratory infections. (1991) (3)
Evidence of a T-cell-mediated cytotoxic response to parainfluenza virus type 3 pneumonia in hamsters. (1982) (3)
Booster effect of oral polio-vaccine. (1969) (3)
Session IV. Ethical, liability and regulatory issues. (2003) (3)
Significance of mycoplasma in respiratory infections of children (1965) (3)
New vaccines for old diseases: trivalent cold-adapted influenza vaccine. (2004) (3)
Influenza: New options for prevention and treatment (2002) (3)
Containing the novel influenza A (H1N1) virus. (2010) (3)
Acute Respiratory Disease Hospitalizations During Respiratory Syncytial Virus Epidemics † 734 (1997) (3)
Measuring the effect of influenza vaccination programs—the Japanese schoolchildren experience revisited (2001) (2)
Prevention of influenza-related morbidity and mortality. (1982) (2)
Influenza immunization of elderly. (1988) (2)
Pneumococcal Carriage in Infants Following Maternal Immunization with Pneumococcal Vaccine or Hemophilus influenzae type b Conjugate Vaccine During Pregnancy † 831 (1998) (2)
1184 SERUM ANTIBODY (Ab) KINETICS FOLLOWING H. INFLUENZAE TYPE B POLYRIBOSEPHOSPHATE (PRP)-DIPHTHERIA TOXOID CONJUGATE (PRP-D) VACCINE GIVEN TO INFANTS: 1 YR FOLLOW-UP AND BOOSTER DOSE RESPONSE (1985) (2)
Influenza virus in pediatric patients. Introduction. (2002) (2)
Association of Mycoplasmataceae, bacteria, and viruses with acute pharyngitis in children (1966) (2)
Containing the Novel Influenza A ( H 1 N 1 ) Virus (2010) (1)
Common viral diseases of childhood. (1972) (1)
Potentiation of the immune response to influenza virus subunit vaccines. (1977) (1)
1011 RISK OF RESPIRATORY SYNCYTIAL (RS) AND PARAINFLUENZA TYPE 3 (PARA3) INFECTION IN YOUNG CHILDREN (1981) (1)
Spectrum of clinical illnesses due to "common cold" viruses in hospitalized patients (1997) (1)
Swine-like influenza vaccine: a commentary. (1976) (1)
Influenza: epidemiology, prevention, and treatment (1990) (1)
A response to strategy #2: streamlining the regulatory process. (2006) (1)
Pneumococcal polysaccharide vaccine in pregnancy. (1999) (1)
Influenza and Its Global Public Health Significance (2007) (1)
EFFECT OF PASSIVE ANTIBODY ON EXPERIMENTAL INFECTION WITH PARAINFLUENZA VIRUS TYPE 3 (PARA3) (1974) (1)
Commentary on the revised vaccine injury table. (1996) (0)
Safety of cold-adapted live influenza vaccine. Authors' reply (2004) (0)
[Influence of influenza epidemics on the urban population]. (1983) (0)
[Surveillance for influenza virus infections in Houston, Texas (author's transl)]. (1981) (0)
Viral Diseases in Childhood (1976) (0)
Letters to the Editor (1981) (0)
Reducing risk of influenza for high-risk children (2010) (0)
Treatment and prevention of influenza virus infections in children (1985) (0)
Pulmonary Nocardiosis in Childhood (2017) (0)
[Prevention of influenza in children]. (2000) (0)
Running Title: Respiratory Viruses and ARI in Hospitalized Patients (2011) (0)
SIGNIFICANCE OF PNEUMOCOCCI AND HEMOPHILUS INFLUENZAE CULTURED FROM THE NASOPHARYNX OF CHILDREN (1974) (0)
Structured guidelines for the use of influenza vaccine among children. (1996) (0)
ADVISABILITY OF AMANTADINE FOR A YOUNG INFANT (1987) (0)
Swine-like influenza virus and vaccine. A commentary. (1976) (0)
Quantitative relationship of pre-existing antibodies to the excretion of attenuated poliovirus (1964) (0)
Influenza B and staphylococcal pneumonia. (1985) (0)
EPIDEMIOLOGY AND DISEASE BURDEN OF INFLUENZA INFECTION IN CHILDREN (2002) (0)
1006 INFLUENZA B IN FAMILIES (1981) (0)
1094 CELLULAR IMMUNE RESPONSES IN FAMILIES WITH INFLUENZA (1981) (0)
Reply to Mercer and Kelly and to Kendall (2011) (0)
Chapter 11 – Influence of Passive Antibodies on the Immune Response of Young Infants (2008) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With William Paul Glezen?

William Paul Glezen is affiliated with the following schools:

William Paul Glezen's Academic­Influence.com Rankings

William Paul Glezen's Degrees

Why Is William Paul Glezen Influential?

William Paul Glezen's Published Works

Published Works

What Schools Are Affiliated With William Paul Glezen?

William Paul Glezen's AcademicInfluence.com Rankings